Literature DB >> 16476482

Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.

Sarah Denniston1, F Andrew I Riordan.   

Abstract

UNLABELLED: Rates of Staphylococcus aureus bacteraemia (SAB) are published performance indicators for hospital-acquired infection. In adults SAB is often associated with central venous catheters (CVC), mortality is high and up to 40% are MRSA. However, there is little data on SAB in neonates and children in the UK. AIM: To describe the presentation, management and outcome of SAB on a neonatal and paediatric unit in a District General Hospital (DGH) over a 10 year period.
METHOD: Case notes of children<16 years with SAB between May 1993 and April 2003 were studied. SAB which developed >48 h after admission was defined as hospital-acquired. Contamination was probable if the clinical picture was unsupportive of infection, or if repeat culture was negative and no treatment was given.
RESULTS: Neonatal unit: Thirty-three of 40 episodes were reviewed (median gestation 32 weeks, median age 21 days). Three of 33 (9%) were contaminants. All SAB were hospital acquired. Twenty-six of 30 (87%) had non-specific presentation, but 15 developed a focus of infection (skin 12, chest 3). Seventeen (57%) infants had CVCs. Eight (27%) infants had MRSA bacteraemia, seven with CVCs. Three (10%) infants died. Paediatric unit: Sixty-four of 70 episodes were reviewed (median age 2 years). Thirteen of 64 (20%) were contaminants. Ten of 51 (20%) were hospital acquired. Presentations were with skin infection 18, bone/joint infection 13, non-specific 13, respiratory 8. Only two had MRSA, one with CVC. One (2%) child died, from an unrelated cause.
CONCLUSION: SAB on a paediatric unit shows a very different pattern compared to SAB in adults. The pattern on a neonatal unit is more similar to that in adults. Both children and neonates have a lower mortality and a lower incidence of MRSA, whilst paediatric SAB has a weaker association with CVC. The proportion of SAB which is hospital acquired is low on a paediatric unit, making SAB an unreliable performance indicator. Most SA in blood cultures are not due to contamination. Prospective studies are needed to determine appropriate investigation and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476482     DOI: 10.1016/j.jinf.2005.11.185

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  14 in total

1.  First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing.

Authors:  S Schlebusch; G R Price; S Hinds; C Nourse; J M Schooneveldt; M H Tilse; H G Liley; T Wallis; F Bowling; D Venter; G R Nimmo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-13       Impact factor: 3.267

2.  Long persistence of methicillin-susceptible strains of Staphylococcus aureus causing sepsis in a neonatal intensive care unit.

Authors:  Carmen Gomez-Gonzalez; Concepción Alba; Joaquín R Otero; Francisca Sanz; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2007-05-23       Impact factor: 5.948

3.  Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Authors:  Kevin M Watt; Christoph P Hornik; Stephen J Balevic; Gratias Mundakel; C Michael Cotten; Barrie Harper; Daniel K Benjamin; Ravinder Anand; Matthew Laughon; P Brian Smith; Michael Cohen-Wolkowiez
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

Review 4.  Identification and control of a gentamicin resistant, meticillin susceptible Staphylococcus aureus outbreak on a neonatal unit.

Authors:  Jonathan A Otter; Bethany Davies; Esse Menson; John L Klein; Timothy L Watts; Angela M Kearns; Bruno Pichon; Jonathan D Edgeworth; Gary L French
Journal:  J Infect Prev       Date:  2014-02-11

Review 5.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review.

Authors:  J O Robinson; J C Pearson; K J Christiansen; G W Coombs; R J Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-11       Impact factor: 3.267

7.  How can the microbiologist help in diagnosing neonatal sepsis?

Authors:  Michela Paolucci; Maria Paola Landini; Vittorio Sambri
Journal:  Int J Pediatr       Date:  2012-01-26

8.  Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.

Authors:  P Brian Smith; C Michael Cotten; Mark L Hudak; Janice E Sullivan; Brenda B Poindexter; Michael Cohen-Wolkowiez; Felix Boakye-Agyeman; Andrew Lewandowski; Ravinder Anand; Daniel K Benjamin; Matthew M Laughon
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.938

9.  Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.

Authors:  J Le; Q Dam; T Tran; A Nguyen; F C Adler-Shohet; S Kim; K Schmidt; J M Lieberman; J S Bradley
Journal:  Epidemiol Infect       Date:  2017-07-27       Impact factor: 4.434

10.  Detection of Oxacillin Resistance in Staphylococcus aureus Isolated from the Neonatal and Pediatric Units of a Brazilian Teaching Hospital.

Authors:  Valéria Cataneli Pereira; André Martins; Lígia Maria Suppo de Souza Rugolo; Maria de Lourdes Ribeiro de Souza da Cunha
Journal:  Clin Med Pediatr       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.